Quote | ImmunityBio Inc. (NASDAQ:IBRX)
Last: | $6.28 |
---|---|
Change Percent: | 0.0% |
Open: | $6.18 |
Close: | $6.28 |
High: | $6.345 |
Low: | $6.17 |
Volume: | 766,530 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | ImmunityBio Inc. (NASDAQ:IBRX)
2024-06-25 15:44:03 ET Summary IBRX has a short interest % of the float of 33%, superior to GME at 21%. Investors should keep an eye on it for short squeeze-fueled volatility. IBRX has positive catalysts on the horizon, such as the commercialization of Anktiva for bladder cancer a...
2024-06-20 12:28:47 ET More on ImmunityBio ImmunityBio: Anktiva's Launch Demands A Reassessment ImmunityBio: Anktiva Approval Opens Up A World Of Possibilities, Risks And Potential Gains ImmunityBio: FDA Approval Gets Ball Rolling Towards Next Set Of Indications ...
Message Board Posts | ImmunityBio Inc. (NASDAQ:IBRX)
Subject | By | Source | When |
---|---|---|---|
The shorts are actually in $IBRX and for | surf1944 | investorshub | 05/11/2023 4:09:31 PM |
Ouch! Sorry to anyone holding. | Cosa | investorshub | 05/11/2023 12:47:23 PM |
FDA denied | LowFloatLopes | investorshub | 05/11/2023 12:20:12 PM |
#$IBRX ?? Will it pullback soon? Price action | da_stock_analyst | investorshub | 05/10/2023 9:59:52 PM |
Looks pretty positive | martind18 | investorshub | 05/10/2023 5:13:27 PM |
News, Short Squeeze, Breakout and More Instantly...
Multiple patients treated across the U.S. with ANKTIVA less than eight weeks after FDA approval of first-in-class cytokine immunotherapy for BCG unresponsive non-muscle invasive bladder cancer ANKTIVA launch initiates the next era of immunotherapy beyond checkpoint inhibitors that is based on...
2024-06-07 10:10:00 ET June 7, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform, releases the second of a two-part series looking at news and developments for the treatment of viruses, featuring Aethlon Medical, Inc. (Nasdaq: AEMD ), a medical the...
ImmunityBio, Inc. ( NASDAQ: IBRX ) announced today that its 2024 Annual Meeting of Stockholders will be held on Tuesday, June 11, 2024 at 9:30 a.m. Pacific Time. The Annual Meeting will be held in a virtual-only format and there will not be a physical location for the Annual Meeting. Stockhol...